COCH · Envoy Medical, Inc.
$0.80
+0.05 (+7.20%)
At close · Aug 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company's ability to continue as a going concern and although management has developed plans intended to support ongoing operations, such plans do not alleviate the substantial doubt.”View the 10-Q filed Aug 10, 2026
Market Cap
$61.76M
Shares
77.19M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brent T. Lucas | Chief Executive Officer and Director | $462,000 |
| Robert M. Potashnick | Interim Chief Financial Officer | $180,766 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brent T. Lucas | Chief Executive Officer and director | $400,542 |
| David R. Wells | Chief Financial Officer | $355,217 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Brent T. Lucas | Chief Executive Officer and director | $1,699,524 |
| David R. Wells | Chief Financial Officer | $583,528 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brent T. Lucas | Chief Executive Officer and director | $265,296 |
| David R. Wells | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Susan J. Kantor | Class III director | Appointed | 2026-05-18 |
| Charles S. McKhann | Class I director | Appointed | 2026-04-21 |
| Glen Taylor | Board of Directors | Resigned | 2025-08-26 |
| Robert Potashnick | Interim Chief Financial Officer | Appointed | 2025-06-25 |
| David R. Wells | Chief Financial Officer | Terminated | 2025-05-19 |
| Michael Crowe | Board | Appointed | 2024-06-11 |
| Whitney Haring-Smith | board of directors | Resigned | 2024-06-11 |
| Daniel Hirsch | executive officer | Resigned | 2023-10-05 |
| Priya Cherian Huskins | director | Resigned | 2023-10-05 |
| Whitney Haring-Smith | executive officer | Resigned | 2023-10-05 |
| Daniel Hirsch | director | Resigned | 2023-10-05 |
| Diane Dewbrey | director | Resigned | 2023-10-05 |
| Charles Brynelsen | chairman of the board of directors | Appointed | 2023-10-05 |
| David R. Wells | Chief Financial Officer | Appointed | 2023-10-05 |
| Brent Lucas | Chief Executive Officer | Appointed | 2023-10-05 |
| Diane L. Dewbrey | member of the Board | Appointed | 2022-10-04 |
| Daniel J. Hirsch | member of the Board | Appointed | 2022-10-04 |
| William Wulfsohn | Chairman of the Board | Resigned | 2022-08-04 |
| Teresa A. Harris | member of the Board | Resigned | 2022-08-04 |
| Peter J. Ganz | General Counsel & Corporate Secretary | Resigned | 2022-08-04 |
Key facts
CIK
1840877
CUSIP
29415V109
13F (30d)
55 filings
55 filers
Visit website
Investor relations